Most Recent
3M is now facing two class actions in Victoria, after being hit with a case on behalf of ADF members who claim they suffered hearing loss from using defective combat earplugs.
Legal fees will eat up more than half of a $3.5 million settlement reached in a class action over deaths at a NSW aged care facility during the COVID-19 pandemic.
Healthcare giant Johnson & Johnson is facing a new class action alleging it sold talcum powder that was contaminated with asbestos and caused reproductive system cancers in women.
US drug maker Pfizer is facing a class action investigation into the possible link between its injectable contraceptive Depo-Provera and brain tumors.
Class action settlements leaped in value last year, with three settlements topping the $200 million mark.
Women who were allegedly injured by defective pelvic mesh implants can apply to set aside two approved settlements against Johnson & Johnson and Boston Scientific worth $405 million.
Funder LLS has urged the court to approve its 20 per cent cut of a $202 million settlement in a stolen wages class action, saying that reducing the "bottom end" rate could deter investments in public interest class actions.
The Commonwealth says funder LLS should not be allowed a 20 per cent cut of a stolen wages class action settlement of up to $202 million, arguing it could produce an “excessive deduction”.
A judge has made a class closure order in a shareholder case against software company Nuix and underwriter Macquarie Capital, but rejected a bid to keep the order in operation until trial.
AMP has won its bid for more information on a class action’s allegations that it charged excessive insurance premiums, saying the applicant appeared to be “in search of a case”.